摘要
目的研究舒利迭(沙美特罗/丙酸氟替卡松)治疗慢性阻塞性肺疾病(COPD)的疗效。方法对98例确诊为COPD的患者随机分成两组,两组均予常规治疗,实验组加用舒利迭(沙美特罗/丙酸氟替卡松,50μg/500μg)吸入,1次/d,两组均于治疗前后测定肺功能指标FEV1、FEV1/FVC及FEV1占预计值的百分率(%),评价治疗前后肺功能的变化,并做圣.乔治(St.George)评分。结果实验组治疗后临床症状积分及上述肺功能指标的明显改善(P<0.05)。结论舒利迭对COPD患者的肺功能有明显的改善作用,并能提高生活质量。
Objective To investigate an effective treatment for chronic obstructive pulmonary disease（COPD）.Methods 98 patients with COPD were randomly divided into two groups,the experiental group and the control group.Patients in the experiental group were given seretide 50 μg/500 μg inhalation once a day and the control group received the inhalation of beclomethasone 50 μg twice a day and the salbutamol aerosol was used once in need.Before and after treatment,thepulmonary functionincluding FEV1,FEV1/FVC and FEV1/predictive value was tested and then the pulmonary functional changes before and after therapy were evaluated.Results In the experimental group,clinical sympton integral and FEV1,FEV1/FVC and FEV1/predictive value were all increased,compared to those before treatment,there were statistically signipicant differences,P0.05.Conclusion Seretide can presently serve as the most ideal medicine for COPD due to its more significant curative effect than that of the single composition or the other compound prepara-tion.
出处
《黑龙江医学》
2011年第1期33-34,共2页
Heilongjiang Medical Journal
关键词
慢性阻塞性肺疾病
舒利迭
肺功能
临床疗效
Chronic obstructive pulmonary diseases（COPD）
Seretide
Lung function
Clinical curative effect
